Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.0B | 1.1B | 1.1B | 1.1B |
Cost of revenue | 358M | 376M | 335M | 391M |
Gross profit | 683M | 728M | 745M | 721M |
Operating expense | ||||
Research & development | 252M | 256M | 253M | 325M |
Selling general and admin | 267M | 279M | 239M | 147M |
Other operating expenses | — | — | — | — |
Operating income | 164M | 193M | 253M | 249M |
Non operating interest income | ||||
Income | 11M | 10M | 11M | 13M |
Expense | 25M | 25M | 36M | 20M |
Other income expense | 32M | 9M | 492M | -2.2B |
Pretax income | 182M | 187M | 720M | -2.0B |
Tax provision | 51M | 0 | 15M | 12M |
Net income | 131M | 187M | 705M | -2.0B |
Basic EPS | 0.8 | 1.2 | 4.4 | -12.5 |
Diluted EPS | 0.8 | 1.2 | 4.4 | -12.5 |
Basic average shares | 159M | 159M | 159M | 159M |
Diluted average shares | 159M | 160M | 160M | 159M |
EBITDA | 276M | 301M | 338M | 35M |
Net income from continuing op. | 131M | 187M | 704M | -2.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |